Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03350750 · ClinicalTrials.gov registry record · NA
A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT03350750: Completed NA study, sponsored by Johns Hopkins University.
NCT03350750 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03350750, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The Placebo-Controlled Effectiveness in Idiopathic Normal Pressure Hydrocephalus (iNPH) Shunting (PENS) trial is a multi-center blinded, randomized, placebo-controlled design investigation of cerebrospinal fluid (CSF) shunt surgery to study the shunt effectiveness in iNPH patients.
Interventions
- DEVICE programmable CSF shunt valve
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2018-05-21 |
| Est. Completion | 2021-05-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03350750
The ClinicalTrials.gov registry entry for NCT03350750 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which programmable CSF shunt valve is the first listed.
NCT03350750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03350750 about?
NCT03350750 is a clinical study titled "A Placebo-Controlled Effectiveness in INPH Shunting (PENS) Trial". The Placebo-Controlled Effectiveness in Idiopathic Normal Pressure Hydrocephalus (iNPH) Shunting (PENS) trial is a multi-center blinded, randomized, placebo-controlled design investigation of cerebrospinal fluid (CSF) shunt surgery to study the shunt effectiveness in iNPH patients.
What is the current status of trial NCT03350750?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2018-05-21. Estimated completion is 2021-05-18.
What interventions are being tested in trial NCT03350750?
The interventions under investigation include: programmable CSF shunt valve (DEVICE).
Who is sponsoring clinical trial NCT03350750?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.